» Articles » PMID: 31933977

MiR-107 Inhibits PDGF-BB-induced Proliferation of Human Pulmonary Arterial Smooth Muscle Cells and Migration Through Targeting NOR1

Overview
Specialty Pathology
Date 2020 Jan 15
PMID 31933977
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Abnormal proliferation of PASMCs is the main phenotype of pulmonary arterial hypertension (PAH). MicroRNAs (miRNAs) were reported to participate in regulating the progression of PAH. Here, we aimed to investigate the impact of miR-107 on proliferation and migration of PASMCs and potential mechanism.

Methods: MTT assay was carried out to examine the cell viability of PASMCs. PASMC migration ability was verified through Transwell assay. RT-qPCR was performed to detect the expression of miR-107 and NOR1. Western blot was conducted to detect the expression of cell proliferation markers Ki-67, p27 and Cyclin D1, as well as NOR1. Bioinformatics analysis was conducted to verify whether the 3'-untranslated region (3'-UTR) of NOR1 contains a binding site for miR-107, and luciferase reporter assay and RNA immunoprecipitation (RIP) were employed to confirm the relationship between miR-107 and NOR1.

Results: Platelet-derived growth factor (PDGF)-BB promoted the cell viability and migration of PASMCs, and suppressed miR-107 expression in a time-dependent and concentration-dependent manner. Introduction of miR-107 inhibited the promotion of proliferation and migration of PASMCs stimulated by PDGF-BB, while loss of miR-107 facilitated PDGF-BB-induced promoted effects. NOR1 was identified as a downstream gene of miR-107 and down-regulated by miR-107. Knockout of NOR1 also repressed the promotion of proliferation and migration of PASMCs stimulated by PDGF-BB. Additionally, restoration of NOR1 attenuated the inhibition of miR-107 on the cell viability and migration ability of PASMCs.

Conclusion: miR-107 inhibits PDGF-BB-induced PASMCs proliferation and migration through targeting NOR1.

Citing Articles

Comprehensive insights into the function and molecular and pharmacological regulation of neuron-derived orphan receptor 1, an orphan receptor.

Hong H, Su J, Huang C, Lu X, Cui Z Front Pharmacol. 2022; 13:981490.

PMID: 36110555 PMC: 9468329. DOI: 10.3389/fphar.2022.981490.


Non-Coding RNA Networks in Pulmonary Hypertension.

Zang H, Zhang Q, Li X Front Genet. 2021; 12:703860.

PMID: 34917122 PMC: 8669616. DOI: 10.3389/fgene.2021.703860.


NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond.

Martinez-Gonzalez J, Canes L, Alonso J, Ballester-Servera C, Rodriguez-Sinovas A, Corrales I Int J Mol Sci. 2021; 22(21).

PMID: 34768801 PMC: 8583700. DOI: 10.3390/ijms222111371.


Blocking circ_UBR4 suppressed proliferation, migration, and cell cycle progression of human vascular smooth muscle cells in atherosclerosis.

Zhang Y, Zhang C, Chen Z, Wang M Open Life Sci. 2021; 16(1):419-430.

PMID: 33981849 PMC: 8085462. DOI: 10.1515/biol-2021-0044.


LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis.

Li Z, Gao L, Zhu X, Xiang D Biochem Genet. 2021; 59(5):1158-1172.

PMID: 33687636 DOI: 10.1007/s10528-021-10053-y.

References
1.
Chen J, Cui X, Qian Z, Li Y, Kang K, Qu J . Multi-omics analysis reveals regulators of the response to PDGF-BB treatment in pulmonary artery smooth muscle cells. BMC Genomics. 2016; 17(1):781. PMC: 5053085. DOI: 10.1186/s12864-016-3122-3. View

2.
Nomiyama T, Zhao Y, Gizard F, Findeisen H, Heywood E, Jones K . Deficiency of the NR4A neuron-derived orphan receptor-1 attenuates neointima formation after vascular injury. Circulation. 2009; 119(4):577-86. PMC: 2748681. DOI: 10.1161/CIRCULATIONAHA.108.822056. View

3.
Wang W, Rajeev B, Stromberg A, Ren N, Tang G, Huang Q . The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008; 28(5):1213-23. PMC: 2837363. DOI: 10.1523/JNEUROSCI.5065-07.2008. View

4.
Sahoo S, Meijles D, Al Ghouleh I, Tandon M, Cifuentes-Pagano E, Sembrat J . MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension. PLoS One. 2016; 11(5):e0153780. PMC: 4856285. DOI: 10.1371/journal.pone.0153780. View

5.
Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A . PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol. 2003; 284(2):C316-30. DOI: 10.1152/ajpcell.00125.2002. View